Cantargia AB (CANTA)

Stockholm
3.85
+0.02(+0.57%)
  • Volume:
    355,120
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    3.82 - 3.97

CANTA Overview

Prev. Close
3.83
Day's Range
3.82-3.97
Revenue
-
Open
3.85
52 wk Range
3.3-18.03
EPS
-4.18
Volume
355,120
Market Cap
642.9M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,175,053
P/E Ratio
-0.874
Beta
1.52
1-Year Change
-78.39%
Shares Outstanding
166,987,895
Next Earnings Date
10 Nov 2022
What is your sentiment on Cantargia AB?
or
Vote to see community's results!

Cantargia AB Company Profile

Cantargia AB Company Profile

Employees
26
Market
Sweden
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0006371126
  • S/N:166987895

Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

Read More

Analyst Price Target

Average30.79 (+699.77% Upside)
High33.2879
Low29.1269
Price3.85
No. of Analysts3
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellSellStrong Sell
Technical IndicatorsStrong SellStrong SellSellSellStrong Sell
SummaryStrong SellStrong SellSellSellStrong Sell